Casaba, Crisanto .

HRN: 23-79-81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2023
CEFTRIAXONE 1G (VIAL)
10/04/2023
10/10/2023
IV
2g
OD
UTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: